ZILRETTA
Peaktriamcinolone acetonide extended-release injectable suspension
NDAINTRA-ARTICULARFOR SUSPENSION, EXTENDED RELEASE
Approved
Oct 2017
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
Drug data last refreshed 14h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ZILRETTA is an extended-release intra-articular suspension of triamcinolone acetonide, a corticosteroid designed for single-dose injection directly into joint spaces. It provides prolonged anti-inflammatory effects for osteoarthritis and other joint conditions, reducing the need for frequent injections. The extended-release formulation allows sustained drug delivery over weeks, improving patient compliance and clinical outcomes.
$0.01BPart D
Peak5.1 years to LOEAt peak lifecycle with minimal Part D penetration (~14 claims in 2023), indicating limited adoption and a mature, stable—rather than growth-oriented—commercial environment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
ZILRETTA is a mature, stable product with very limited current job openings and modest commercial activity (14 Part D claims in 2023), suggesting a small, efficient commercial team. Working on this product would focus on market maintenance and managed care negotiations rather than high-growth brand expansion.
Brand ManagerMedical Science Liaison
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.